Brian M. Hahn
2020
In 2020, Brian M. Hahn earned a total compensation of $1.2M as Senior Vice President and Chief Financial Officer at GlycoMimetics.
Compensation breakdown
| Bonus | $202,500 |
|---|---|
| Non-Equity Incentive Plan | $175,203 |
| Option Awards | $409,200 |
| Salary | $417,150 |
| Other | $8,667 |
| Total | $1,212,720 |
Hahn received $417.2K in salary, accounting for 34% of the total pay in 2020.
Hahn also received $202.5K in bonus, $175.2K in non-equity incentive plan, $409.2K in option awards and $8.7K in other compensation.
Rankings
In 2020, Brian M. Hahn's compensation ranked 7,795th out of 13,090 executives tracked by ExecPay. In other words, Hahn earned more than 40.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,795 out of 13,090 | 41st |
Division Manufacturing | 3,292 out of 5,621 | 41st |
Major group Chemicals And Allied Products | 1,335 out of 2,254 | 41st |
Industry group Drugs | 1,158 out of 1,954 | 41st |
Industry Pharmaceutical Preparations | 862 out of 1,459 | 41st |
Source: SEC filing on April 11, 2022.
Hahn's colleagues
We found one more compensation record of an executive who worked with Brian M. Hahn at GlycoMimetics in 2020.
2020
Rachel King
GlycoMimetics
Chief Executive Officer
News
GlycoMimetics CEO Harout Semerjian's 2023 pay jumps 67% to $2.4M
April 1, 2024
GlycoMimetics CEO Harout Semerjian's 2022 pay falls 50% to $1.4M
April 21, 2023
GlycoMimetics CEO Harout Semerjian receives $2.9M in 2021
April 11, 2022
GlycoMimetics CEO Rachel King's 2018 pay jumps 105% to $3.2M
April 10, 2019